LRN Stride, Inc.

NYSE stridelearning.com


$ 152.20 $ 0.17 (0.11 %)    

Friday, 24-Oct-2025 15:59:59 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 152.11
$ 153.18
$ 150.55 x 20
$ 153.00 x 10
$ 151.00 - $ 154.95
$ 89.11 - $ 171.17
468,733
na
6.64B
$ 0.49
$ 23.05
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-K
2 04-29-2025 03-31-2025 10-Q
3 01-28-2025 12-31-2024 10-Q
4 10-22-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-K
6 04-23-2024 03-31-2024 10-Q
7 01-23-2024 12-31-2023 10-Q
8 10-24-2023 09-30-2023 10-Q
9 08-15-2023 06-30-2023 10-K
10 04-26-2023 03-31-2023 10-Q
11 01-25-2023 12-31-2022 10-Q
12 10-26-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-K
14 04-19-2022 03-31-2022 10-Q
15 01-25-2022 12-31-2021 10-Q
16 10-19-2021 09-30-2021 10-Q
17 08-10-2021 06-30-2021 10-K
18 04-21-2021 03-31-2021 10-Q
19 01-27-2021 12-31-2020 10-Q
20 10-27-2020 09-30-2020 10-Q
21 08-12-2020 06-30-2020 10-K
22 04-28-2020 03-31-2020 10-Q
23 01-28-2020 12-31-2019 10-Q
24 10-23-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-K
26 04-24-2019 03-31-2019 10-Q
27 01-23-2019 12-31-2018 10-Q
28 10-24-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-K
30 04-25-2018 03-31-2018 10-Q
31 01-26-2018 12-31-2017 10-Q
32 10-27-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-K
34 04-28-2017 03-31-2017 10-Q
35 01-27-2017 12-31-2016 10-Q
36 10-26-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-K
38 04-27-2016 03-31-2016 10-Q
39 01-28-2016 12-31-2015 10-Q
40 10-27-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 canaccord-genuity-maintains-buy-on-stride-raises-price-target-to-175

Canaccord Genuity analyst Jason Tilchen maintains Stride (NYSE:LRN) with a Buy and raises the price target from $165 to $175.

 barrington-research-maintains-outperform-on-stride-maintains-185-price-target

Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and maintains $185 price target.

 barrington-research-maintains-outperform-on-stride-raises-price-target-to-185

Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and raises the price target from $...

 morgan-stanley-maintains-equal-weight-on-stride-raises-price-target-to-159

Morgan Stanley analyst Greg Parrish maintains Stride (NYSE:LRN) with a Equal-Weight and raises the price target from $148 to...

 stride-q4-eps-229-beats-174-estimate-sales-65365m-beat-62627m-estimate

Stride (NYSE:LRN) reported quarterly earnings of $2.29 per share which beat the analyst consensus estimate of $1.74 by 31.31 pe...

 barrington-research-maintains-outperform-on-stride-maintains-170-price-target

Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and maintains $170 price target.

 barrington-research-maintains-outperform-on-stride-raises-price-target-to-170

Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and raises the price target from $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION